Is this you? Create Your Porfile
Avatar

Scott L. Harbeson

Vertex Pharmaceuticals

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Scott L. Harbeson is active.

Explore More

Publication

Featured researches published by Scott L. Harbeson.

Archive | 2003

Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

Roger D. Tung; Scott L. Harbeson; David D. Deininger; Mark A. Murcko; Govinda Rao Bhisetti; Luc J. Farmer

Archive | 2003

Heteroaryl compounds useful as inhibitors of GSK-3

Scott L. Harbeson; Michael J. Arnost; Jeremy Green; Vladimir Savic

Bioorganic & Medicinal Chemistry Letters | 2004

Inhibitors of hepatitis C virus NS3·4A protease 2. Warhead SAR and optimization

Robert B. Perni; Janos Pitlik; Shawn D. Britt; John J. Court; Lawrence F. Courtney; David D. Deininger; Luc J. Farmer; Cynthia A. Gates; Scott L. Harbeson; Rhonda B. Levin; Chao Lin; Kai Lin; Young-Choon Moon; Yu-Ping Luong; Ethan T. O'Malley; B. Govinda Rao; John A. Thomson; Roger D. Tung; John H. Van Drie; Yunyi Wei

Bioorganic & Medicinal Chemistry Letters | 2004

Inhibitors of hepatitis C virus NS3·4A protease. Part 3: P2 proline variants

Robert B. Perni; Luc J. Farmer; Kevin M. Cottrell; John J. Court; Lawrence F. Courtney; David D. Deininger; Cynthia A. Gates; Scott L. Harbeson; Joseph L. Kim; Chao Lin; Kai Lin; Yu-Ping Luong; John Maxwell; Mark A. Murcko; Janos Pitlik; B. Govinda Rao; Wayne C. Schairer; Roger D. Tung; John H. Van Drie; Keith P. Wilson; John A. Thomson

Bioorganic & Medicinal Chemistry Letters | 2003

Inhibitors of hepatitis C virus NS3.4A protease 1. Non-charged tetrapeptide variants.

Robert B. Perni; Shawn D. Britt; John C. Court; Lawrence F. Courtney; David D. Deininger; Luc J. Farmer; Cynthia A. Gates; Scott L. Harbeson; Joseph L. Kim; James A. Landro; Rhonda B. Levin; Yu-Ping Luong; Ethan T. O'Malley; Janos Pitlik; B.Govinda Rao; Wayne C. Schairer; John A. Thomson; Roger D. Tung; John H. Van Drie; Yunyi Wei

Archive | 2004

Aminofurazan compounds useful as protein kinase inhibitors

Jon H. Come; Jeremy Green; Craig Marhefka; Scott L. Harbeson; Ly Pham

Archive | 2003

Inhibitors of Jak protein kinase

Guy W. Bemis; Scott L. Harbeson; Mark Ledeboer

Archive | 2003

Thiadiazoles or oxadiazoles and their use as inhibitors of JAK protein kinase

Guy W. Bemis; Scott L. Harbeson; Mark Ledeboer

Archive | 2002

2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors

Jeremy Green; Scott L. Harbeson; John Cochran

Archive | 2010

Heteroaryl compound useful as inhibitor of gsk-3

Michael J. Arnost; Jeremy Green; Scott L. Harbeson; Vladimir Savic; サビック ヴラディーミル; グリーン ジェレミー; エル． ハーベソン スコット; ジェイ． アーノスト マイケル

Explore More

Collaboration

Dive into the Scott L. Harbeson's collaboration.

Top Co-Authors
Avatar

Jeremy Green

University of Wisconsin-Madison

View shared research outputs
Top Co-Authors
Avatar

David D. Deininger

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Luc J. Farmer

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Roger D. Tung

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Craig Marhefka

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Guy W. Bemis

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Jon H. Come

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Ly Pham

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Mark Ledeboer

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Michael J. Arnost

Vertex Pharmaceuticals

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge